Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Logos Global Management LP (CIK 1792126) reported $2.00B across 58 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: RVMD ($194.5M, 9.71%), ERAS ($180.4M, 9.01%), IDYA ($115.0M, 5.74%), TERN ($105.4M, 5.26%), PRAX ($91.8M, 4.58%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | $194.5M | 9.71% | 2.0M | Trimmed |
| 2 | ERAS | ERASCA INC | $180.4M | 9.01% | 11.2M | Trimmed |
| 3 | IDYA | IDEAYA BIOSCIENCES INC | $115.0M | 5.74% | 3.5M | Trimmed |
| 4 | TERN | TERNS PHARMACEUTICALS INC | $105.4M | 5.26% | 2.0M | Added |
| 5 | PRAX | PRAXIS PRECISION MEDICINES I | $91.8M | 4.58% | 285,000 | Trimmed |
| 6 | CNTA | CENTESSA PHARMACEUTICALS PLC | $84.4M | 4.21% | 2.1M | Added |
| 7 | ABVX | ABIVAX SA | $75.2M | 3.75% | 675,000 | Added |
| 8 | TNGX | TANGO THERAPEUTICS INC | $62.8M | 3.13% | 3.0M | Trimmed |
| 9 | CYTK | CYTOKINETICS INC | $57.7M | 2.88% | 875,000 | Added |
| 10 | OLMA | OLEMA PHARMACEUTICALS INC | $47.8M | 2.39% | 3.2M | Hold |
| 11 | UTHR | UNITED THERAPEUTICS CORP DEL | $47.4M | 2.37% | 80,000 | New |
| 12 | IMCR | IMMUNOCORE HLDGS PLC | $45.2M | 2.26% | 1.5M | Added |
| 13 | MDGL | MADRIGAL PHARMACEUTICALS INC | $44.5M | 2.22% | 85,000 | New |
| 14 | ELVN | ENLIVEN THERAPEUTICS INC | $40.8M | 2.04% | 1.0M | Added |
| 15 | RYTM | RHYTHM PHARMACEUTICALS INC | $39.1M | 1.95% | 450,000 | Added |
| 16 | CGON | CG ONCOLOGY INC | $38.9M | 1.94% | 575,000 | Added |
| 17 | MAZE | MAZE THERAPEUTICS INC | $36.9M | 1.84% | 1.2M | Added |
| 18 | BIIB | BIOGEN INC | $36.7M | 1.83% | 200,000 | Hold |
| 19 | IRON | DISC MEDICINE INC | $35.8M | 1.79% | 560,000 | Added |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | $33.6M | 1.68% | 400,000 | Added |
| 21 | TYRA | TYRA BIOSCIENCES INC | $32.6M | 1.63% | 850,000 | Added |
| 22 | OCUL | OCULAR THERAPEUTIX INC | $32.6M | 1.63% | 3.9M | Added |
| 23 | TRVI | TREVI THERAPEUTICS INC | $28.6M | 1.43% | 2.4M | Added |
| 24 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $28.0M | 1.40% | 1.5M | Trimmed |
| 25 | IMVT | IMMUNOVANT INC | $26.7M | 1.33% | 1.1M | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31